HotStockMarket › Forums › HSM Stock Forum › Penny Stocks › ENMD - EntreMed
New Posts  All Forums:Forum Nav:

ENMD - EntreMed

post #1 of 963
Thread Starter 
ENMD - EntreMed



About EntreMed

EntreMed, Inc. is a clinical-stage pharmaceutical company developing therapeutic candidates primarily for the treatment of cancer and inflammation. MKC-1 is currently in multiple Phase 2 clinical trials for cancer. MKC-1 is an oral cell-cycle regulator with activity against the mTOR pathway. Panzem(R) (2-methoxyestradiol) NCD is also in multiple Phase 2 studies in oncology patients. Additionally, ENMD-1198, a novel tubulin-binding agent, is in Phase 1 studies in advanced cancers. The Company has approved IND applications for Panzem(R) in rheumatoid arthritis, and ENMD-2076, a dual-acting Aurora- angiogenesis inhibitor, for cancer. EntreMed's goal is to develop and commercialize new compounds based on the Company's expertise in angiogenesis, cell-cycle regulation and inflammation - processes vital to the treatment of cancer and other diseases, such as rheumatoid arthritis. Additional information about EntreMed is available on the Company's web site at www.entremed.com and in various filings with the Securities and Exchange Commission.
post #2 of 963
Thread Starter 
ENMD is up 8% today, coming off support at $1.15 on news that they are entering phase II trails for ovarian cancer.

EntreMed Commences Phase 2 Study With MKC-1 in Ovarian/Endometrial Cancers
Multi-Center Clinical Trial to be Conducted in Canada

ROCKVILLE, Md., Jan. 23 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, today announced the commencement of a Phase 2 study with its novel cell cycle inhibitor, MKC-1, in recurrent or resistant epithelial ovarian cancer and advanced endometrial cancer patients. The study will be conducted at multiple sites in Canada with Dr. Amit Oza, Senior Staff Physician and Associate Professor of Medicine, Princess Margaret Hospital, University of Toronto, serving as the principal investigator.
post #3 of 963
Thread Starter 
$1.19 today
post #4 of 963
Thread Starter 
Stock lost support, hit 51c, now rebounding to 75c
post #5 of 963
Set to move? Looks good to me...
post #6 of 963
Thread Starter 
Hmm, just popped on my scanner with a volume spike +25%

Cant see any news, but this 50c-70c has been a trading range. Sellers will most likely start coming out here between 70c and 80c.
post #7 of 963
I'm guessing this spike has to do with tommy's pick
post #8 of 963
Quote:
Originally Posted by MoDat View Post
I'm guessing this spike has to do with tommy's pick
Most likely. He announced the ENMD his new stock pick today. After about 3 mins his new stock pick was announced as ENMD, it rose 25%
post #9 of 963
open a short position @ 0.70
looking for cover today or tomorrow
post #10 of 963
Quote:
Originally Posted by coldwind View Post
open a short position @ 0.70
looking for cover today or tomorrow
haha coldwind! you're back. It's time to bash on ENMD now?
post #11 of 963
Quote:
Originally Posted by coldwind View Post
open a short position @ 0.70
looking for cover today or tomorrow
haha its a good thing hes back! he was ragging on cvm when it was around the same price and we all know how cvm did
post #12 of 963
yeah~ I got in early this time
post #13 of 963
I´m not even an expert of chart science but i think it´s a big resistance between 0.70-75.

Anyone more experienced to confirm ?
post #14 of 963
Interesting stock for sure. I don't think it will take off overnight but then again you never know. Word can spread very quickly and perhaps a bunch could jump on it... who knows. Eitherway I added it to my watch list.
post #15 of 963
StockJock-e, what do you think about this stock?
post #16 of 963
ENMD has a drug that apparently has or is about to finish phase I trials on one of their cancer drugs.
From what I read on different forums it should be released soon, I hope so and I hope it is good, then ENMD should be looking really nice.

For those who wonder about my pharma picks, here they are.

KERX at .18 cents, currently $2.29
ANSV at .07 cents, it hit $1.49 after my pick.
NVD at .08 cents, hit .88 cents after my pick.
CVM at .50 cents, it hit $2.10 and is currently $1.44

Now lets hope for the same thing with ENMD.
post #17 of 963
Quote:
Originally Posted by TOMMYGUN View Post
ENMD has a drug that apparently has or is about to finish phase I trials on one of their cancer drugs.
From what I read on different forums it should be released soon, I hope so and I hope it is good, then ENMD should be looking really nice.

For those who wonder about my pharma picks, here they are.

KERX at .18 cents, currently $2.29
ANSV at .07 cents, it hit $1.49 after my pick.
NVD at .08 cents, hit .88 cents after my pick.
CVM at .50 cents, it hit $2.10 and is currently $1.44

Now lets hope for the same thing with ENMD.
Nice Rep.
post #18 of 963
Well...here goes the thread from 2 pages to 800 pages in T-Minus...

post #19 of 963
just added 3k of ENMD
post #20 of 963
Quote:
Originally Posted by mmm...Jaz View Post
Well...here goes the thread from 2 pages to 800 pages in T-Minus...

New Posts  All Forums:Forum Nav:
  Return Home
  Back to Forum: Penny Stocks
HotStockMarket › Forums › HSM Stock Forum › Penny Stocks › ENMD - EntreMed